The use of gonadotropin-releasing hormone agonist to regulate oocyte retrieval time.
We investigated the use of a gonadotropin-releasing hormone agonist (GnRH-a) to assist in the synchronous entry of a fixed number of subjects into in vitro fertilization (IVF) and gamete intrafallopian tube transfer cycle. Using a protocol in which a GnRH-a was given in the follicular or luteal phase, the clinical pregnancy rate per procedure was 27%. We conclude that the use of a GnRH-a for synchronous cycles in IVF-embryo transfer is efficacious and results in acceptable pregnancy rates.
Department of Obstetrics and Gynecology, Oregon Health Sciences, University School of Medicine, Portland.
P E
PE
Patton
D
D
Eaton
K A
KA
Burry
D P
DP
Wolf
D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D015181:Gamete Intrafallopian Transfer; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology*; D006801:Humans; D008597:Menstrual Cycle; D009865:Oocytes; D010062:Ovulation Induction; D011247:Pregnancy; D013048:Specimen Handling; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone